You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Omicron vaccine

Showing 26 - 50 of 8,312
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

COVID-19 Trial in United States (XBB.1.5 Vaccine (Booster), XBB.1.5 Vaccine (single dose))

Not yet recruiting
  • COVID-19
  • XBB.1.5 Vaccine (Booster)
  • XBB.1.5 Vaccine (single dose)
  • Mobile, Alabama
  • +29 more
Aug 4, 2023

SARS-CoV-2 Trial in Bengbu (COVID-19 Variant (Omicron BA.5) mRNA Vaccine Low dose, COVID-19 Variant (Omicron BA.5) mRNA Vaccine

Recruiting
  • SARS-CoV-2
  • COVID-19 Variant (Omicron BA.5) mRNA Vaccine Low dose
  • +2 more
  • Bengbu, Anhui, China
    First Affiliated Hospital Bengbu Medical College
Jan 3, 2023

COVID-19 Trial (ABO1009-DP)

Not yet recruiting
  • COVID-19
  • ABO1009-DP
  • (no location specified)
Jul 11, 2022

Sars-CoV-2 Infection Trial in South Africa (Alveavax-v1.2, Janssen Ad26.COV2.S)

Completed
  • Sars-CoV-2 Infection
  • Bloemfontein, Free State, South Africa
  • +7 more
May 2, 2023

COVID-19 Pandemic Trial in China (SCTV01E, Placebo (normal saline))

Recruiting
  • COVID-19 Pandemic
  • SCTV01E
  • Placebo (normal saline)
  • Lianshui, Jiangsu, China
  • +3 more
Jan 5, 2023

COVID-19, SARS-CoV-2 Infection Trial (SCTV01E-2, SCTV01E)

Not yet recruiting
  • COVID-19
  • SARS-CoV-2 Infection
  • SCTV01E-2
  • SCTV01E
  • (no location specified)
Jul 4, 2023

COVID-19 Pandemic Trial in Shaoguan (V-01/V-01-B5, V-01-351/V-01-B5, V-01)

Active, not recruiting
  • COVID-19 Pandemic
  • V-01/V-01-B5
  • +2 more
  • Shaoguan, Guangdong, China
    Shaoguan Hospital of Chinese Medicine
Nov 3, 2022

COVID-19 Trial in United States (mRNA-CR-04 vaccine 10µg, mRNA-CR-04 vaccine 30µg, mRNA-CR-04 vaccine 100µg)

Not yet recruiting
  • COVID-19
  • mRNA-CR-04 vaccine 10μg
  • +3 more
  • San Diego, California
  • +3 more
Aug 1, 2023

COVID-19 Vaccines, Varicella Zoster Vaccine, Vaccine Response Trial in Netherlands (COVID-19 vaccination)

Not yet recruiting
  • COVID-19 Vaccines
  • +3 more
  • COVID-19 vaccination
  • Nijmegen, Gelderland, Netherlands
  • +6 more
Jun 29, 2023

COVID-19 Trial in Barranquilla (Trivalent COVID-19 Vaccine (Vero Cell), Inactivated, Prototype Strain, Delta Strain and Omicron

Not yet recruiting
  • COVID-19
  • Trivalent COVID-19 Vaccine (Vero Cell), Inactivated, Prototype Strain, Delta Strain and Omicron Strain
  • COVID-19 Vaccine (Vero Cell), Inactivated
  • Barranquilla, Colombia
    Clinica de la Costa
Jun 23, 2022

COVID-19 Trial in United States (NVX-CoV2373 (5µg), NVX-CoV2601 (5µg), NVX-CoV2601(5µg))

Not yet recruiting
  • COVID-19
  • NVX-CoV2373 (5μg)
  • +6 more
  • Birmingham, Alabama
  • +47 more
Jul 2, 2023

COVID-19 Trial in Wuhan (Prototype and Omicron BA.4/5 Bivalent Recombinant COVID-19 Vaccine(Adenovirus Type 5 Vector) For

Recruiting
  • COVID-19
  • Prototype and Omicron BA.4/5 Bivalent Recombinant COVID-19 Vaccine(Adenovirus Type 5 Vector) For Inhalation
  • +2 more
  • Wuhan, Hubei, China
    Zhongnan Hospital of Wuhan University
Jun 1, 2023

COVID-19, SARS-CoV-2 Infection Trial (SCTV01C, SCTV01E, mRNA vaccine manufactured by Pfizer or Moderna)

Not yet recruiting
  • COVID-19
  • SARS-CoV-2 Infection
  • SCTV01C
  • +3 more
  • (no location specified)
Apr 1, 2022

COVID-19 SARS-CoV-2 Infection Trial (CoronaVac, SCTV01E)

Not yet recruiting
  • COVID-19 SARS-CoV-2 Infection
  • CoronaVac
  • SCTV01E
  • (no location specified)
Jan 4, 2023

COVID-19, SARS-CoV-2 Infection Trial (SCTV01E, mRNA-1273)

Not yet recruiting
  • COVID-19
  • SARS-CoV-2 Infection
  • SCTV01E
  • mRNA-1273
  • (no location specified)
Apr 25, 2022

COVID-19, SARS CoV 2 Infection Trial in Australia (NVX-CoV2515, NVX-Cov2373, NVX-CoV2373 + NVX-CoV2515)

Active, not recruiting
  • COVID-19
  • SARS CoV 2 Infection
  • Bruce, Australian Capital Territory, Australia
  • +18 more
Nov 23, 2022

COVID-19, SARS-CoV-2 Infection Trial (SCTV01C, SCTV01E, Sinopharm inactivated COVID-19 vaccine)

Not yet recruiting
  • COVID-19
  • SARS-CoV-2 Infection
  • SCTV01C
  • +3 more
  • (no location specified)
Apr 1, 2022

COVID-19 Trial in United States (drug, biological, other)

Active, not recruiting
  • COVID-19
  • Birmingham, Alabama
  • +21 more
Feb 2, 2023

COVID-19, SARS-CoV-2 Infection Trial (SCTV01C, SCTV01E, Sinopharm inactivated COVID-19 vaccine)

Not yet recruiting
  • COVID-19
  • SARS-CoV-2 Infection
  • SCTV01C
  • +3 more
  • (no location specified)
Apr 10, 2022

SARS-CoV-2 Infection, COVID-19 Trial (SCTV01E, Comirnaty)

Not yet recruiting
  • SARS-CoV-2 Infection
  • COVID-19
  • SCTV01E
  • Comirnaty
  • (no location specified)
Apr 11, 2022

COVID-19, SARS-CoV-2 Infection Trial (SCTV01E, CoronaVac, Sinopharm inactivated COVID-19 vaccine)

Not yet recruiting
  • COVID-19
  • SARS-CoV-2 Infection
  • SCTV01E
  • +3 more
  • (no location specified)
Apr 1, 2022

COVID-19, Sars-CoV-2 Infection Trial (SCTV01E, Comirnaty)

Not yet recruiting
  • COVID-19
  • Sars-CoV-2 Infection
  • SCTV01E
  • Comirnaty
  • (no location specified)
Feb 14, 2022

SARS-CoV-2 Trial in United Kingdom (mRNA-1273.529, mRNA-1273, mRNA-1273.214)

Recruiting
  • SARS-CoV-2
  • mRNA-1273.529
  • +2 more
  • Aberdeen, Aberdeenshire, United Kingdom
  • +28 more
Apr 11, 2022

COVID-19 Trial in Melbourne (Tozinameran, Elasomeran, Bivalent Pfizer-BioNTech)

Not yet recruiting
  • COVID-19
  • Tozinameran
  • +3 more
  • Melbourne, Victoria, Australia
    Royal Children's Hospital, Murdoch Children's Research Institute
Sep 14, 2022

COVID-19 Trial in Kunming (RQ3013, RQ3025, RQ3027)

Recruiting
  • COVID-19
  • RQ3013
  • +2 more
  • Kunming, Yunnan, China
    The Affiliated Hospital of Yunnan University
Jun 22, 2023